Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma

References

• Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–548. .
   PubMed Web of Science ®Google Scholar
• Ri M. Mechanism of action of bortezomib in multiple myeloma therapy. Int J Myeloma. 2016;6:1–6.
   Google Scholar
• Nakamura M, Gotoh T, Okuno Y, et al. Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leuk Lymphoma. 2006;47:531–539.
   PubMed Web of Science ®Google Scholar
• Luo S, Mao C, Lee B, et al. GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development. Mol Cell Biol. 2006;26:5688–5697.
   PubMed Web of Science ®Google Scholar
• Wey S, Luo B, Lee AS. Acute inducible ablation of GRP78 reveals its role in hematopoietic stem cell survival, lymphogenesis and regulation of stress signaling. PLoS One. 2012;7:e39047.
   PubMed Web of Science ®Google Scholar
• Sun F-C, Wei S, Li C-W, et al. Localization of GRP78 to mitochondria under the unfolded protein response. Biochem J. 2006;396:31–39.
   PubMed Web of Science ®Google Scholar
• Ni M, Zhang Y, Lee AS. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem J. 2011;434:181–188.
   PubMed Web of Science ®Google Scholar
• Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334:1081–1086.
   PubMed Web of Science ®Google Scholar
• Lin JH, Walter P, Yen TSB. Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol Mech Dis. 2008;3:399–425.
   PubMed Web of Science ®Google Scholar
• Nagelkerke A, Bussink J, Sweep FCGJ, et al. The unfolded protein response as a target for cancer therapy. Biochim Biophys Acta - Rev Cancer. 2014;1846:277–284.
   PubMed Web of Science ®Google Scholar
• Grootjans J, Kaser A, Kaufman RJ, et al. The unfolded protein response in immunity and inflammation. Nat Rev Immunol. 2016;16:469–484.
   PubMed Web of Science ®Google Scholar
• Baumeister P, Luo S, Skarnes WC, et al. Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol Cell Biol. 2005;25:4529–4540.
   PubMed Web of Science ®Google Scholar
• Kouroku Y, Fujita E, Tanida I, et al. ER stress (PERK/eIF2a phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 2007;14:230–239.
   PubMed Web of Science ®Google Scholar
• Rashid HO, Yadav RK, Kim HR, et al. ER stress: autophagy induction, inhibition and selection. Autophagy. 2015;11:1956–1977.
   PubMed Web of Science ®Google Scholar
• Mujcic H, Nagelkerke A, Rouschop KMA, et al. Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3. Clin Cancer Res. 2013;19:6126–6137.
   PubMed Web of Science ®Google Scholar
• Ohoka N, Yoshii S, Hattori T, et al. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. Embo J. 2005;24:1243–1255.
   PubMed Web of Science ®Google Scholar
• Law AYS, Wong CKC. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res. 2010;316:466–476.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Matsui T, Yamamoto A, et al. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001;107:881–891.
   PubMed Web of Science ®Google Scholar
• Lisbona F, Rojas-Rivera D, Thielen P, et al. BAX inhibitor-1 Is a negative regulator of the ER stress sensor IRE1α. Mol Cell. 2009;33:679–691.
   PubMed Web of Science ®Google Scholar
• Ni M, Lee AS ER chaperones in mammalian development and human diseases. FEBS Lett. 2007. p. 3641–3651.
   Google Scholar
• Munro S, Pelham HRA. C-terminal signal prevents secretion of luminal ER proteins. Cell. 1987;48:899–907.
   PubMed Web of Science ®Google Scholar
• Tsai Y-L, Zhang Y, Tseng -C-C, et al. Characterization and mechanism of stress-induced translocation of 78-kilodalton glucose-regulated protein (GRP78) to the cell surface. J Biol Chem. 2015;290:8049–8064.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu R, Ni M, et al. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J Biol Chem. 2010;285:15065–15075.
   PubMed Web of Science ®Google Scholar
• Llewellyn DH, Roderick HL, Rose S. KDEL receptor expression is not coordinatedly up-regulated with ER stress-induced reticuloplasmin expression in HeLa cells. Biochem Biophys Res Commun. 1997;240:36–40.
   PubMed Web of Science ®Google Scholar
• Burikhanov R, Zhao Y, Goswami A, et al. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell. 2009;138:377–388.
   PubMed Web of Science ®Google Scholar
• Triantafilou M, Fradelizi D, Triantafilou K. Major histocompatibility class one molecule associates with glucose regulated protein (GRP) 78 on the cell surface. Hum Immunol. 2001;62:764–770.
   PubMed Web of Science ®Google Scholar
• Triantafilou K, Fradelizi D, Wilson K, et al. GRP78, a Coreceptor for Coxsackievirus A9, Interacts with Major Histocompatibility Complex Class I Molecules Which Mediate Virus Internalization. J Virol. 2002;76:633–643.
   PubMed Web of Science ®Google Scholar
• Shin BK, Wang H, Yim AM, et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem. 2003;278:7607–7616.
   PubMed Web of Science ®Google Scholar
• Al-Rawashdeh FY, Scriven P, Cameron IC, et al. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2010;22:1099–1105.
   PubMed Web of Science ®Google Scholar
• Kang BR, Yang SH, Chung BR, et al. Cell surface GRP78 as a biomarker and target for suppressing glioma cells. Sci Rep. 2016;6:34922.
   PubMed Web of Science ®Google Scholar
• Daneshmand S, Quek ML, Lin E, et al. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol. 2007;38:1547–1552.
   PubMed Web of Science ®Google Scholar
• Zhang J, Jiang Y, Jia Z, et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis. 2006;23:401–410.
   PubMed Web of Science ®Google Scholar
• Fernandez PM, Tabbara SO, Jacobs LK, et al. Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat. 2000;59:15–26.
   PubMed Web of Science ®Google Scholar
• Rosati E, Sabatini R, Rampino G, et al. Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. Blood. 2010;116:2713–2723.
   PubMed Web of Science ®Google Scholar
• Quach H, North D, Freddi S, et al. High GRP78 (78-kDa glucose-regulated protein) expression predicts for a favorable clinical outcome in patients with multiple myeloma and may be a potentially useful therapeutic target in the treatment of multiple myeloma. Blood. 2015;126:4206.
   Web of Science ®Google Scholar
• Lee AS. Glucose regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat Rev Cancer. 2014;14:263–276.
   PubMed Web of Science ®Google Scholar
• Ninkovic S, Straszkowski L, Dey A, et al. Cell surface glucose-regulated protein 78 (GRP78) is upregulated in plasma cells of patients with multiple myeloma compared to monoclonal gammopathy of uncertain significance. Clin Lymphoma Myeloma Leuk. 2019;19:e95–e96.
   PubMed Web of Science ®Google Scholar
• Lizardo MM, Morrow JJ, Miller TE, et al. Upregulation of glucose-regulated protein 78 in metastatic cancer cells is necessary for lung metastasis progression. Neoplasia. 2016;18:699–710.
   PubMed Web of Science ®Google Scholar
• Lee E, Nichols P, Groshen S, et al. GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy. Int J Cancer. 2011;128:726–731.
   PubMed Web of Science ®Google Scholar
• Verras M, Papandreou I, Lim AL, et al. Tumor hypoxia blocks Wnt processing and secretion through the induction of endoplasmic reticulum stress. Mol Cell Biol. 2008;28:7212–7224.
   PubMed Web of Science ®Google Scholar
• Rao RV, Peel A, Logvinova A, et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 2002;514:122–128.
   PubMed Web of Science ®Google Scholar
• Reddy RK, Mao C, Baumeister P, et al. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors. Role of ATP binding site in suppression of caspase-7 activation. J Biol Chem. 2003;278:20915–20924.
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang Y, Fu Y, et al. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78). J Biol Chem. 2011;286:25687–25696.
   PubMed Web of Science ®Google Scholar
• Tseng YZCC, Tsai YL, Fu X, et al. Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production. PLoS One. 2013;8:e80071.
   PubMed Web of Science ®Google Scholar
• Shani G, Fischer WH, Justice NJ, et al. GRP78 and cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor signaling and enhance cell growth. Mol Cell Biol. 2008;28:666–677.
   PubMed Web of Science ®Google Scholar
• Liu R, Li X, Gao W, et al. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clin Cancer Res. 2013;19:6802–6811.
   PubMed Web of Science ®Google Scholar
• Wey S, Luo B, Tseng CC, et al. Inducible knockout of GRP78/BiP in the hematopoietic system suppresses PTEN-null leukemogenesis and AKT oncogenic signaling. Blood. 2012;119:817–825.
   PubMed Web of Science ®Google Scholar
• Gopal U, Gonzalez-Gronow M, Pizzo SV. Activated α2-macroglobulin regulates transcriptional activation of c-MYC target genes through cell surface GRP78 protein. J Biol Chem. 2016;291:10904–10915.
   PubMed Web of Science ®Google Scholar
• Misra UK, Deedwania R, Pizzo SV. Binding of activated α2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK. J Biol Chem. 2005;280:26278–26286.
   PubMed Web of Science ®Google Scholar
• Misra UK, Deedwania R, Pizzo SV. Activation and cross-talk between Akt, NF-κB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J Biol Chem. 2006;281:13694–13707.
   PubMed Web of Science ®Google Scholar
• Kelber JA, Panopoulos AD, Shani G, et al. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene. 2009;28:2324–2336.
   PubMed Web of Science ®Google Scholar
• de Castro NP, Rangel MC, Nagaoka T, et al. Cripto-1: an embryonic gene that promotes tumorigenesis. Futur Oncol. 2010;6:1127–1142.
   PubMed Web of Science ®Google Scholar
• Zoni E, Chen L, Karkampouna S, et al. CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer. Oncogene. 2017;36:4739–4749.
   PubMed Web of Science ®Google Scholar
• Gray PC, Vale W. Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis. FEBS Lett. 2012;586:1836–1845.
   PubMed Web of Science ®Google Scholar
• Kouznetsova VL, Hu H, Teigen K, et al. Cripto stabilizes GRP78 on the cell membrane. Protein Sci. 2018;27:653–661.
   PubMed Web of Science ®Google Scholar
• Miharada K, Karlsson G, Rehn M, et al. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche. Ann N Y Acad Sci. 2012;1266:55–62.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhang Y, Yu VC, et al. Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction. Cell Death Differ. 2014;21:797–810.
   PubMed Web of Science ®Google Scholar
• Xiang W, Ke Z, Zhang Y, et al. Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice. J Cell Mol Med. 2011;15:359–374.
   PubMed Web of Science ®Google Scholar
• Cao Y, Chen A, An SSA, et al. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem. 1997;272:22924–22928.
   PubMed Web of Science ®Google Scholar
• Davidson DJ, Haskell C, Majest S, et al. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res. 2005;65:4663–4672.
   PubMed Web of Science ®Google Scholar
• Ahn JH, Yu HK, Lee HJ, et al. Suppression of colorectal cancer liver metastasis by apolipoprotein(a) kringle V in a nude mouse model through the induction of apoptosis in tumor-associated endothelial cells Lee JW, editor. PLoS One. 2014;9:e93794.
   PubMed Web of Science ®Google Scholar
• Oida T, Weiner HL. TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction. Unutmaz D, editor. PLoS One. 2010;5:e15523.
   PubMed Web of Science ®Google Scholar
• Corrigall VM, Vittecoq O, Panayi GS. Binding immunoglobulin protein-treated peripheral blood monocyte-derived dendritic cells are refractory to maturation and induce regulatory T-cell development. Immunology. 2009;128:218–226.
   PubMed Web of Science ®Google Scholar
• Huergo-Zapico L, Gonzalez-Rodriguez AP, Contesti J, et al. Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding. Cancer Immunol Immunother. 2012;61:1201–1210.
   PubMed Web of Science ®Google Scholar
• Katanasaka Y, Ishii T, Asai T, et al. Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78. Int J Cancer. 2010;127:2685–2698.
   PubMed Web of Science ®Google Scholar
• Philippova M, Ivanov D, Joshi MB, et al. Identification of proteins associating with glycosylphosphatidylinositol- anchored T-cadherin on the surface of vascular endothelial cells: role for Grp78/BiP in T-cadherin-dependent cell survival. Mol Cell Biol. 2008;28:4004–4017.
   PubMed Web of Science ®Google Scholar
• Visioli F, Wang Y, Alam GN, et al. Glucose-regulated protein 78 (Grp78) confers chemoresistance to tumor endothelial cells under acidic stress. Di YP, editor. PLoS One. 2014;9:e101053.
   PubMed Web of Science ®Google Scholar
• Virrey JJ, Dong D, Stiles C, et al. Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells. Mol Cancer Res. 2008;6:1268–1275.
   PubMed Web of Science ®Google Scholar
• Dong D, Stapleton C, Luo B, et al. A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res. 2011;71:2848–2857.
   PubMed Web of Science ®Google Scholar
• Kern J, Untergasser G, Zenzmaier C, et al. GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib. Blood. 2009;114:3960–3967.
   PubMed Web of Science ®Google Scholar
• Misra UK, Mowery Y, Kaczowka S, et al. Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis. Mol Cancer Ther. 2009;8:1350–1362.
   PubMed Web of Science ®Google Scholar
• Misra UK, Pizzo SV. Modulation of the unfolded protein response in prostate cancer cells by antibody-directed against the carboxyl-terminal domain of GRP78. Apoptosis. 2010;15:173–182.
   PubMed Web of Science ®Google Scholar
• Misra UK, Pizzo SV. Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells. Cancer Biol Ther. 2010;9:142–152.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gronow M, Cuchacovich M, Llanos C, et al. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. Cancer Res. 2006;66:11424–11431.
   PubMed Web of Science ®Google Scholar
• Steiner N, Borjan B, Hajek R, et al. Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma. Oncotarget. 2017;8:56243–56254.
   PubMedGoogle Scholar
• Ninkovic S, Harrison S, Straszkowski L, et al. Higher intensity of cell surface glucose-regulated protein 78 (csGRP78) expression is seen in patients with early progressive disease/mortality in a cohort of relapsed, refractory multiple myeloma patients treated with carfilzomib, thalidomide and dexamethasone. Blood. 2019;134:4376.
   Web of Science ®Google Scholar
• Obeng EA, Carlson LM, Gutman DM, et al. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006;107:4907–4916.
   PubMed Web of Science ®Google Scholar
• Dong H, Chen L, Chen X, et al. Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells. Leuk Lymphoma. 2009;50:974–984.
   PubMed Web of Science ®Google Scholar
• Jagannathan S, Abdel-Malek MAY, Malek E, et al. Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib. Leukemia. 2015;29:2184–2191.
   PubMed Web of Science ®Google Scholar
• Rauschert N, Brändlein S, Holzinger E, et al. A new tumor-specific variant of GRP78 as target for antibody-based therapy. Lab Investig. 2008;88:375–386.
   PubMed Web of Science ®Google Scholar
• Jiang D, Niwa M, Koong AC. Targeting the IRE1α-XBP1 branch of the unfolded protein response in human diseases. Semin Cancer Biol. 2015;33:48–56.
   PubMed Web of Science ®Google Scholar
• Rasche L, Duell J, Morgner C, et al. The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78. Han Z, editor. PLoS One. 2013;8:e63414.
   PubMed Web of Science ®Google Scholar
• Rasche L, Duell J, Castro IC, et al. GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6. Haematologica. 2015;100:377–384.
   PubMed Web of Science ®Google Scholar
• Leo R, Emmanuelle M, Valentina D, et al. A GRP78-Directed monoclonal antibody recaptures response in refractory multiple myeloma with extramedullary involvement. Clin Cancer Res. 2016;22:4341–4349.
   PubMed Web of Science ®Google Scholar
• Kao C, Chandna R, Ghode A, et al. Proapoptotic cyclic peptide BC71 targets cell-surface GRP78 and functions as an anticancer therapeutic in mice. EBioMedicine. 2018;33:22–32.
   PubMed Web of Science ®Google Scholar
• Larson N, Gormley A, Frazier N, et al. Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia. J Control Release. 2013;170:41–50.
   PubMed Web of Science ®Google Scholar
• Staquicini DI, D’Angelo S, Ferrara F, et al. Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates. Pharmacogenomics J. 2018;18:436–443.
   PubMed Web of Science ®Google Scholar
• D’Angelo S, Staquicini FI, Ferrara F, et al. Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications. JCI Insight. 2018;3:e98305.
   PubMed Web of Science ®Google Scholar